ED files chargesheet in Rs 211 crore Insurance Medical Services fraud

HYDERABAD : The Enforcement Directorate (ED) has filed a prosecution complaint (chargesheet) in the Rs 211 crore Insurance Medical Services (IMS) fraud under the Prevention of Money Laundering Act (PMLA).
Charges have been filed against the then IMS director Dr Devika Rani and 15 other accused, including representatives of several drug firms and pharma company owners.
ED had already attached properties worth Rs 144 crore. The accused had allegedly resorted to financial irregularities in the supply of medicines and other surgical kits to dispensaries and Employee’s State Insurance (ESI) hospitals across Telangana.
ED’s PMLA case is based on eight FIRs registered by the Anti-Corruption Bureau (ACB) against the accused for violations in the tender process, misappropriation of public funds and causing loss to the state exchequer. Dr Devika Rani and others are alleged to have conspired with medicine and medical equipment suppliers and issued purchase orders in violation of norms.

The chargesheet alleges that Dr Rani, in collusion with other IMS staff, violated all norms with supplier K Srihari Babu and also benami firms set up by the IMS chief and P Rajeshwar Reddy.

The prices of medical items were inflated, and indents and stock registers were fabricated. Another key accused, Dr K Padma, who was joint director IMS, was found to be siphoning off medicines and supplies in the name of medical camps.

Dr Rani and pharmacist Nagalaxmi allegedly conspired with PMJ Jewellers and purchased jewellery worth around `6.3 crore without bills using the scam money. The accused also invested in real estate. The scam mostly took place between 2015-16 and 2018-19. Several shell firms were floated to layer the money. The ED had attached villas, open plots, commercial shops and agricultural land parcels in Hyderabad, Bengaluru, and Noida.

Related Posts

Systech launches TraceIQ, an intelligent and easy-to-use platform to transform pharma traceability from compliance to operational intelligence

Systech, a global leader in pharmaceutical serialization and traceability solutions, announced the launch of Systech TraceIQ, an intelligent, easy-to-use enterprise traceability platform created for a new operational reality in pharmaceutical…

Amway India launches range of new products under Nutrilite Ayurveda

In a decisive move aligned with India’s nation-building priorities and the Viksit Bharat 2047 vision, Amway India, a leading health and wellbeing company, announced a landmark strategic push into Ayurveda…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Systech launches TraceIQ, an intelligent and easy-to-use platform to transform pharma traceability from compliance to operational intelligence

Systech launches TraceIQ, an intelligent and easy-to-use platform to transform pharma traceability from compliance to operational intelligence

Amway India launches range of new products under Nutrilite Ayurveda

Amway India launches range of new products under Nutrilite Ayurveda

Yashoda Medicity’s Medical Tourism Footprint widens with Republic of Kazakhstan on Board

Yashoda Medicity’s Medical Tourism Footprint widens with Republic of Kazakhstan on Board

Liver enters FATal Straits in India, AIIMS Experts red flag

Liver enters FATal Straits in India, AIIMS Experts red flag

Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump says

Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump says

FIR against 22 foreign medical graduates for uploading fake docus on Maharashtra Medical Council portal to obtain temporary registration without clearing screening test

FIR against 22 foreign medical graduates for uploading fake docus on Maharashtra Medical Council portal to obtain temporary registration without clearing screening test